Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral neuropathy.

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...

Will radiation make you radioactive? Does radiation therapy hurt? Doctors explain 5 facts about this cancer treatment.

SAN ANTONIO — Texas Oncology – San Antonio teamed up with Angeles Sin Fronteras to provide free wigs and cosmetic kits to ...

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced perip ...

GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. (HealthDay News) — The pooled prevalence of chronic ...

A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...